| scholarly article | Q13442814 |
| P50 | author | Myron F. Weiner | Q37370228 |
| Linda S. Hynan | Q37370246 | ||
| P2093 | author name string | Matthew W Warren | |
| P2860 | cites work | cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain | Q22010155 |
| Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis | Q22242405 | ||
| Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging | Q24629027 | ||
| Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease | Q24630213 | ||
| The incidence of dementia: a meta-analysis | Q45174488 | ||
| Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. | Q46745937 | ||
| Circulating leptin levels and weight loss in Alzheimer's disease patients | Q47220287 | ||
| Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol | Q48161830 | ||
| Obesity, leptin, and the brain | Q49159541 | ||
| Change in body mass index and risk of incident Alzheimer disease. | Q50769923 | ||
| Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. | Q52044615 | ||
| Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface | Q59306995 | ||
| Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke | Q61881937 | ||
| Education and change in cognitive function. The Epidemiologic Catchment Area Study | Q72185912 | ||
| Serum leptin concentration in women: effect of age, obesity, and estrogen administration | Q77362396 | ||
| “Mini-mental state” | Q25938989 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease | Q28216782 | ||
| Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease | Q28268162 | ||
| Leptin and the regulation of body weight in mammals | Q29615976 | ||
| Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity | Q29616103 | ||
| Low levels of high density lipoprotein increase the severity of cerebral white matter changes: implications for prevention and treatment of cerebrovascular diseases. | Q33573845 | ||
| Reduced lean mass in early Alzheimer disease and its association with brain atrophy | Q33791606 | ||
| Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model | Q33915820 | ||
| Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study | Q33941073 | ||
| Brain cholesterol: long secret life behind a barrier. | Q33975527 | ||
| Leptin: a novel therapeutic strategy for Alzheimer's disease | Q34015256 | ||
| Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices | Q34075070 | ||
| Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease | Q34154473 | ||
| Obesity and leptin resistance: distinguishing cause from effect | Q34259053 | ||
| Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo | Q34514599 | ||
| Obesity, abdominal obesity and Alzheimer disease | Q34548468 | ||
| Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons | Q34663462 | ||
| Body mass index and cognitive decline in mild cognitive impairment | Q34746728 | ||
| A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease | Q35144361 | ||
| Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles | Q35700985 | ||
| Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. | Q36076075 | ||
| Leptin and its role in hippocampal synaptic plasticity | Q36470247 | ||
| Lipoprotein receptors – an evolutionarily ancient multifunctional receptor family | Q36486210 | ||
| Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo | Q36662772 | ||
| Serum leptin level and cognition in the elderly: Findings from the Health ABC Study | Q37612838 | ||
| Adiposity hormones and dementia | Q37793535 | ||
| Level of education and change in cognitive function in a community population of older persons. | Q41096967 | ||
| Meal timing, fasting and glucocorticoids interplay in serum leptin concentrations and diurnal profile | Q44086732 | ||
| Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study | Q44438334 | ||
| Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity | Q44526989 | ||
| Obesity-related leptin regulates Alzheimer's Abeta | Q45171528 | ||
| P433 | issue | 1 | |
| P921 | main subject | lipid | Q11367 |
| Alzheimer's disease | Q11081 | ||
| P304 | page(s) | 151-157 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Lipids and adipokines as risk factors for Alzheimer's disease | |
| P478 | volume | 29 |
| Q36767745 | Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology |
| Q38300217 | Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's disease. |
| Q47644425 | Adiponectin and sporadic Alzheimer's disease: Clinical and molecular links. |
| Q89964020 | Adipose-Derived Molecules-Untouched Horizons in Alzheimer's Disease Biology |
| Q36103515 | Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD). |
| Q58616641 | Association between Peripheral Leptin and Adiponectin Levels and Cognitive Decline in Patients with Neurocognitive Disorders ≥65 Years |
| Q41039610 | Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia. |
| Q99585529 | Blood-based protein mediators of senility with replications across biofluids and cohorts |
| Q38255757 | Body mass index in dementia |
| Q94599763 | Causal association of circulating cholesterol levels with dementia: a mendelian randomization meta-analysis |
| Q59048785 | Clinicotherapeutic Potential of Leptin in Alzheimer’s Disease and Parkinson’s Disease |
| Q36325378 | Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study |
| Q33623924 | Estrogen: a master regulator of bioenergetic systems in the brain and body |
| Q36436743 | HDL-cholesterol and apolipoproteins in relation to dementia |
| Q38763488 | Higher visceral fat is associated with lower cerebral N-acetyl-aspartate ratios in middle-aged adults. |
| Q41357850 | Importance of adiponectin activity in the pathogenesis of Alzheimer's disease |
| Q47860207 | Interrelationship between Mini-Mental State Examination scores and biochemical parameters in patients with mild cognitive impairment and Alzheimer's disease |
| Q37066904 | Leptin and cognition. |
| Q89819854 | Low-Density Lipoprotein Cholesterol and Alzheimer's Disease: A Systematic Review and Meta-Analysis |
| Q34241108 | Menopause Analytical Hormonal Correlate Outcome Study (MAHCOS) and the association to brain electrophysiology (P300) in a clinical setting |
| Q26799893 | Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment |
| Q38189680 | Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines |
| Q34761266 | Peptides from adipose tissue in mental disorders |
| Q51760271 | Physiological changes in neurodegeneration - mechanistic insights and clinical utility. |
| Q33677202 | Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in mice |
| Q90263981 | The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer's Dementia |
| Q64077317 | U-Shaped Relationship between Serum Leptin Concentration and Cognitive Performance in Older Asian Adults |
| Q36651514 | Very old adults with better memory function have higher low-density lipoprotein cholesterol levels and lower triglyceride to high-density lipoprotein cholesterol ratios: KOCOA Project |
Search more.